Skip to navigation Skip to sub-navigation Skip to content

People

Fabio Gallazzi

Fabio Gallazzi

Research Assistant Professor

Phone: 573-882-9024 or 573-884-1281
gallazzif@missouri.edu
471b Life Sciences Center

2021

Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents. Spratt AN, Gallazzi F, Quinn TP, Lorson CL, Sönnerborg A, Singh K. Expert Opinion on Therapeutic Patents; 31(4):339-350.

Date published: January 1, 2021
Featured in this article: Fabio Gallazzi, Thomas Quinn, Christian Lorson, Kamlendra Singh.

Go to article...

2020

Therapeutic peptide delivery: Via aptamer-displaying, disulfide-linked peptide amphiphile micelles. Smith JD, Cardwell LN, Porciani D, Nolla A, Cornelison BT, Schulte MC, Gallazzi F, Burke DH, Daniels MA, Ulery BD. Molecular Systems Design and Engineering; 5(1):269-283.

Date published: January 1, 2020
Featured in this article: David Porciani, Fabio Gallazzi, Donald Burke-Agüero.

Go to article...

2019

GS-CA compounds: First-in-class HIV-1 capsid inhibitors covering multiple grounds. Singh K, Gallazzi F, Hill KJ, Burke DH, Lange MJ, Quinn TP, Neogi U, Sönnerborg A. Frontiers in Microbiology; 10(JUN):1227.

Date published: June 20, 2019
Featured in this article: Kamlendra Singh, Fabio Gallazzi, Donald Burke-Agüero, Margaret Lange, Thomas Quinn.

Go to article...

2018

Aptamer-displaying peptide amphiphile micelles as a cell-targeted delivery vehicle of peptide cargoes. Smith JD, Cardwell LN, Porciani D, Nguyen JA, Zhang R, Gallazzi F, Tata RR, Burke DH, Daniels MA, Ulery BD. Physical Biology; 15(6):065006.

Date published: October 22, 2018
Featured in this article: David Porciani, Fabio Gallazzi, Donald Burke-Agüero.

Go to article...

2008

Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA-peptide conjugates. Jia F, Figueroa SD, Gallazzi F, Balaji BS, Hannink M, Lever SZ, Hoffman TJ, Lewis MR. Journal of Nuclear Medicine; 49(3):430-438.

Date published: March 1, 2008
Featured in this article: Fabio Gallazzi, Mark Hannink.

Go to article...

2003

Synthesis of Radiometal-Labeled and Fluorescent Cell-Permeating Peptide-PNA Conjugates for Targeting the bcl-2 Proto-oncogene. Gallazzi F, Wang Y, Jia F, Shenoy N, Landon LA, Hannink M, Lever SZ, Lewis MR. Bioconjugate Chemistry; 14(6):1083-1095.

Date published: November 1, 2003
Featured in this article: Fabio Gallazzi, Mark Hannink.

Go to article...

2002

Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: Preparation, characterization, and in vitro mRNA binding. Lewis MR, Jia F, Gallazzi F, Wang Y, Zhang J, Shenoy N, Lever SZ, Hannink M. Bioconjugate Chemistry; 13(6):1176-1180.

Date published: November 1, 2002
Featured in this article: Fabio Gallazzi, Mark Hannink.

Go to article...